From early phase, to patients
Path-to-Market strategy is about options: choices for how to take a molecule to market, optimising for clinical, regulatory and commercial hurdles.
You need a way to generate path to market choices, and a way to decide between them. That's where we come in.
There is a window of opportunity to differentiate by design
Delivering our Path to Market service.
The methodology, the discipline of making choices about Path to Market.
1 Deep insight on the talents of your molecule, creativity to challenge the 'obvious'
2 Create a longlist of differentiating path to market ideas
3 Methodology to generate a robust shortlist
4 Conduct external pressure testing of the choices
Path to market insights and innovation.
You can't develop tomorrow's medicines with yesterday's thinking.
A look into the metrics behind the Pharmaceutical Innovation and Invention Index
IDEA Pharma’s Pharmaceutical Invention and Innovation Index has become an industry standard in annually ranking the industry’s top ~30 companies in their ability to develop meaningful novel treatments, as well as commercializing them successfullyRead article